Comparison of Outcomes of Mismatched Related Stem Cell and Unrelated Cord Blood Transplants in Children with Severe T-Cell Deficiencies.
Juliana Folloni Fernandes(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Marina Cavazzana(Université Rennes 2), Bénédicte Neven(Université Paris-Panthéon-Assas), Carmem Bonfim(Universidade Federal do Paraná), Andrew R. Gennery(Newcastle upon Tyne Hospitals NHS Foundation Trust), Ansgar Schulz(University Hospital Ulm), Alain Fischer(Inserm), Michael Grimley(Cincinnati Children's Hospital Medical Center), Myriam Labopin(Sorbonne Université), Paul Landais(Centre Hospitalier Universitaire de Montpellier), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Paul Veys(Great Ormond Street Hospital), H. Bobby Gaspar(University College London), Mary Slatter(First Pavlov State Medical University of St. Petersburg), Mouhab Ayas(King Faisal Specialist Hospital & Research Centre), Ka Wah Chan(Methodist Children’s Hospital), Yves Bertrand(Université Claude Bernard Lyon 1), Tayfun Güngör, Fulvio Porta(Ospedale dei Bambini Vittore Buzzi), Wolfram Ebell(Charité - Universitätsmedizin Berlin), Vanderson Rocha(European Organisation for Rare Diseases), Donna A. Wall(University of Manitoba), Wilhelm Friedrich, Krzysztof Kałwak(Poznan University of Medical Sciences)
Cited by 3
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k